Earnings Call · Q3 FY2023·2023-11-16

Q3 23EPS +20.37%·Rev n/aQ2 23EPS +28.57%·Rev n/aQ1 23EPS -15.52%·Rev n/aQ4 22EPS +100.00%*·Rev n/a⚠ consensus missing

ABEONA THERAPEUTICS INC. ABEO

Greg Gin — Head of Investor Relations

Vishwas Seshadri — Chief Executive Officer

Madhav Vasanthavada — Chief Commercial Officer

Joseph Vazzano — Chief Financial Officer

+10.0%1d on move date+10.1% vs SPY3d+1.5%5d+2.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABEO calls or request research access.

More ABEO calls Browse calls Request research access